Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies
- Resource Type
- Article
- Source
- In
Journal of Geriatric Oncology January 2020 11(1):19-23 - Subject
- Language
- ISSN
- 1879-4068